Fettke H, Kostos L, Docanto M, Bukczynska P, et al. Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [(177)Lu]Lu-PSMA-617. Eur Urol 2025 Oct 29:S0302-2838(25)00501-9. doi: 10.1016/j.eururo.2025.
PMID: 41168066